Moods Disorders Completed Phase 2 Trials for Buspirone (DB00490)

Also known as: Mood Disorder / Mood Disorders / Affective disorder / Mood disorder NOS / Affective psychosis NOS / Affective disorder NOS / Affective disorders NOS / Affecive disorder NOS

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00149617Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1Treatment